Reagents
Ended Awarded Last action
- Contract number
- 75N91025F00012
- Awardee
-
Illumina, Inc. UEI KMW3CRWNAAF3
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $133,163
Award facts
- Contract value 100% obligated
- $133,163.10 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 334516 Analytical Laboratory Instrument Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Not Competed Only One Source
- Pricing
- Firm Fixed Price
- Place of performance
- San Diego, CA 92122, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Terminate for Convenience | -$116,275 | |
| Other Administrative Action | $0 | |
| Original award | $249,439 |
About this award
This is a federal contract award to Illumina, Inc., a leading manufacturer of genetic sequencing and genomic analysis technologies, by the National Cancer Institute (NCI), a civilian agency within the National Institutes of Health (NIH). The $133,163.10 firm fixed-price delivery order contract is for the procurement of reagents to support the NCI's research initiatives. The contract does not have a set-aside designation.
Illumina has been awarded multiple federal contracts and grants from various agencies, including the NIH, Centers for Disease Control and Prevention, Department of Agriculture, Department of Veterans Affairs, and Food and Drug Administration. These contracts typically involve the procurement of Illumina's advanced sequencing instruments, such as the NextSeq, NovaSeq, and MiSeq systems, along with associated reagents, consumables, maintenance services, and bioinformatics software. Illumina also holds Indefinite Delivery Vehicles with the Department of Veterans Affairs, valued at over $1.5 million, to enable the flexible procurement of their products and services across multiple VA facilities.
Quick answers
Who was awarded contract 75N91025F00012?
75N91025F00012 was awarded to Illumina, Inc. by National Cancer Institute (National Institutes of Health) on February 18, 2025.
How much is contract 75N91025F00012 worth?
The government has obligated $133,163 on 75N91025F00012.
Is contract 75N91025F00012 an order under another contract?
Yes. 75N91025F00012 is a delivery order under 75N92020D00022, an indefinite delivery contract.
Was contract 75N91025F00012 competed?
The extent of competition for 75N91025F00012 was not competed.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award